Company profilePharmaceutical#189 of 1,318 in Pakistan✓ No DRAP alerts

ALLIANCE PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 94 brands · 95 molecules

Ranked #64 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

94 registered products 33 pharmaceutical brands 95 distinct molecules 0 DRAP alerts

Company overview

94
registered products
33
pharmaceutical brands
95
distinct molecules
12
therapeutic classes
0
DRAP alerts

ALLIANCE PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 94 product registrations across 95 distinct molecules. It is the 189th largest registrant in Pakistan by product count, and ranks 64th of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antispasmodic & Anticholinergic. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 5Antispasmodic & Anticholinergic · 2Ace Inhibitor · 2Other Beta-Lactam, Cephalosporins & Penems · 2Antianemic, Iron Preparations · 2Antimalarials · 1Calcium Channel Blockers · 1Antimigraine Preparations · 1Cough And Cold Preparations · 1Quinolone Antibacterials · 1Antiemetics & Antinauseants · 1Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for ALLIANCE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.